Announced Tue, 14 Jul · 16:30 IST
Mirae Asset MF cuts stake in Gland Pharma by 0.18% to 4.98%
GLAND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+2.8%1-day move
₹2477.00
prior close
₹2500.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.1-0.3-0.1-0.0+2.8-1.1-0.8+0.3-1.5-3.6————
Up moveDown movePending
AI summary
Mirae Asset Mutual Fund sold 300,972 shares (0.18%) of Gland Pharma in the open market on July 13, 2026. Its holding fell from 5.17% (8,511,810 shares) to 4.98% (8,210,838 shares). This is a disclosure under SEBI's takeover regulations. Mirae Asset is not classified as a promoter of Gland Pharma.
Likely market impact
Minor FII selling; holding remains well below key regulatory thresholds. No promoter action involved, so limited direct price impact expected.